The Human Microbiome-based Gut Health Test and Nutrition Market Size is valued at 129.23 Billion in 2022 and is predicted to reach 885.52 Billion by the year 2030 at a 28.5 % CAGR during the forecast period for 2023-2030.
Microorganisms found in the human body are known as human microbiomes. The human gut contains trillions of microorganisms (also known as microbiota or microbes) from thousands of different species, including bacteria and fungus, parasites, and viruses. Each person has a unique group of microbiota consisting of both helpful and potentially harmful microbes. In a healthy person, these microbiomes coexist, with the largest numbers found in the small and large intestines and throughout the body. Some are beneficial to health, while others are not, but both play an essential role in digestion and respiratory cycles.
In a healthy body, pathogenic and symbiotic microbiota coexist without problems. The nutrition to the human gut, i.e. probiotics provided to the gut, are live microorganisms that harness the human microbiome's power to develop scientifically-validated nutritional involvements that promote human health and reduce disease risk. Microbiota accelerates the immune system, breaks down potentially toxic food compounds, and synthesizes certain vitamins and amino acids, including B and vitamin K.
The diagnosis of human gut health is made with gut health test kits, which help diagnose the health and population of gut microbiota of infants, adults, and pregnant women. Gut health mentions the balance of microorganisms in the digestive tract. The importance of gut health and maintaining the right balance of bacteria is vital for immunity, physical and emotional well-being, and more.
The mechanisms driving the market of Human Microbiome-based Gut Health Test and Nutrition effects may directly or indirectly involve microbiota modulation or may instead be driven by other means, such as direct immune activation, enzyme production, or gut barrier interaction. Increasing collaborations within private and public organizations will provide essential opportunities. An increasing number of global Consumer Packaged Goods companies, the Emergence of technologically advanced start-ups, and biotechs companies will play a significant role in the worldwide market growth. In addition, Human Nutrition Summits and the introduction of innovative products and business growth through strategic alliances, mergers, and acquisitions among key players will push the market growth upward. In Nov 2020, Atlas Biomed launched its at-home gut health test kit in Japan as a part of its personalized nutrition service. In Nov 2019, Seed Health Announced a Research Partnership with Atmo Biosciences to Evaluate the Impact of Probiotics With the First Ingestible Gas Sensor Technology. However, a High intake of antibiotics and other supplements may restrain the global market.
Due to the COVID-19 pandemic, the general consumer has become more aware of establishing good baseline health, gut health, and immunity, enhancing the gut health testing market.
Market Segmentation
The human microbiome-based gut health test and nutrition market are segmented into the end-users, products, and regions. The end-user segment includes three types adult, maternal, and infant. Secondly, the product segment consists of four main categories-D2C Gut Health Test, Probiotic supplements, Personalized nutrition, and Microbiome modulators. The modulator category comprises Ingredients, Medical food, and Therapeutics. On the basis of Region, The human microbiome-based gut health test and nutrition market is categorized into North America, Asia Pacific, Europe, Latin America, the Middle East, and Africa.
Regionally North America is likely to witness rapid growth during the forecast period (2022-2030) due to increased demand and the massive impact of COVID-19. Companies are awarded huge funds for research on live microbiome ingredients and the development of new products
Competitive Landscape
Some Of The Key Players In The Human Microbiome-based Gut Health Test and Nutrition Market:
- Seed Health,
- ResBiotic,
- Fitbiomics,
- HSK Genetech,
- Mybacs,
- ISOThrive,
- Nouri,
- Bayer Consumer Health,
- Clasado Biosciences,
- CometBio,
- Essential formulae,
- ExeGi, Kerry,
- Immune Biotech,
- Pendulum Therapeutics,
- Evolve Biosystems,
- Gerber,
- Lovebug probiotics,
- Mommy's Bliss,
- Zarbees,
- Mamasselect,
- Hyperbiotics,
- Everidis,
- Floraster,
- Enfamil,
- Culturelle,
- Biogaia,
- Viome,
- Atlas Biomed,
- Flore,
- Bioms,
- Ombre,
- Biohm,
- Affinity DNA,
- Freshly fermented,
- Carbiotix,
- Troo,
- Verisana,
- Throne,
- Phable,
- Biomesight,
- Invivo,
- Neovos,
- The BioArte,
- Holobiome,
- Bio & Me,
- Nexbiome,
- Holobiome,
- Finch Therapeutics,
- Byheart,
- Mybiotics,
- Vedanta Biosciences,
- Other Prominent Players
The Human Microbiome-based Gut Health Test and Nutrition Market Report Scope
|
Report Attribute |
Specifications |
|
Market Size Value In 2022 |
USD 129.23 Billion |
|
Revenue Forecast In 2030 |
USD 885. 52 Billion |
|
Growth Rate CAGR |
CAGR of 28.5 % from 2023 to 2030 |
|
Quantitative Units |
Representation of revenue in US$ Billion and CAGR from 2023 to 2030 |
|
Historic Year |
2019 to 2022 |
|
Forecast Year |
2023-2030 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Product, By End-User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
Seed Health, ResBiotic, Fitbiomics, HSK Genetech, Mybacs, ISOThrive, Nouri, Bayer Consumer Health, Clasado Biosciences, CometBio, Essential formulae, ExeGi, Kerry, Immune Biotech, Pendulum Therapeutics, Evolve Biosystems, Gerber, Lovebug probiotics, Mommy's Bliss, Zarbees, Mamasselect, Hyperbiotics, Everidis, Floraster, Enfamil, Culturelle, Biogaia, Viome, Atlas Biomed, Flore, Bioms, Ombre, Biohm, Affinity DNA, Freshly fermented, Carbiotix, Troo, Verisana, Throne, Phable, Biomesight, Invivo, Neovos, The BioArte, Holobiome, Bio & Me, Nexbiome, Holobiome, Finch Therapeutics, Byheart, Mybiotics, Vedanta Biosciences, Other Prominent Players |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
